DMKPQ (DMK Pharmaceuticals) Other Current Liabilities: $3.43 Mil (As of Sep. 2023)


DMKPQ DMK Pharmaceuticals Corp DMKPQ
16 GF Score
Price $0.00
View Full Analysis

What is DMK Pharmaceuticals Other Current Liabilities?

DMK Pharmaceuticals DMKPQ -99.00% 16 Other Current Liabilities is $3.43 Mil as of Sep. 2023. GuruFocus rates DMKPQ with a GF Score™ of 16/100.

DMK Pharmaceuticals's other current liabilities for the quarter that ended in Sep. 2023 was $3.43 Mil.

DMK Pharmaceuticals's quarterly other current liabilities increased from Mar. 2023 ($1.06 Mil) to Jun. 2023 ($1.11 Mil) and increased from Jun. 2023 ($1.11 Mil) to Sep. 2023 ($3.43 Mil).

DMK Pharmaceuticals's annual other current liabilities declined from Dec. 2020 ($12.71 Mil) to Dec. 2021 ($3.68 Mil) and declined from Dec. 2021 ($3.68 Mil) to Dec. 2022 ($1.58 Mil).

DMK Pharmaceuticals Other Current Liabilities Related Terms

DMK Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for DMK Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMK Pharmaceuticals Other Current Liabilities Chart

DMK Pharmaceuticals Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 12.71 3.68 1.58

DMK Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.58 1.06 1.11 3.43
DMKPQ
16GF Score
DMK Pharmaceuticals Corp DMKPQ
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DMK Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $3.43 Mil mean?
DMK Pharmaceuticals (DMKPQ) has a Other Current Liabilities of $3.43 Mil as of Sep. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DMK Pharmaceuticals.
Is DMK Pharmaceuticals' Other Current Liabilities too high?
DMK Pharmaceuticals' current Other Current Liabilities is $3.43 Mil. Overall, DMK Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does DMK Pharmaceuticals' Other Current Liabilities compare to CNNC and THCT?
DMK Pharmaceuticals' Other Current Liabilities of $3.43 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DMK Pharmaceuticals. DMK Pharmaceuticals's current Other Current Liabilities is $3.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DMK Pharmaceuticals stock overvalued right now?
DMK Pharmaceuticals (DMKPQ) has a current Other Current Liabilities of $3.43 Mil. The current Other Current Liabilities is $3.43 Mil. DMK Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For DMK Pharmaceuticals (DMKPQ), the current Other Current Liabilities is $3.43 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DMK Pharmaceuticals Business Description

Address 11682 El Camino Real, Suite 300, San Diego, CA, USA, 92130
DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
16GF Score

Get the complete analysis for DMKPQ

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price